# EDGAR Filing Document

**Accession Number:** 0001726884
**File Stem:** 0001127602-23-010058
**Filing Date:** 2023-3
**Character Count:** 8144
**Document Hash:** c7fda442e548a6dd32c1b907d1779902
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-010058.hdr.sgml**: 20230314

**ACCESSION NUMBER**: 0001127602-23-010058

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230313

**FILED AS OF DATE**: 20230314

**DATE AS OF CHANGE**: 20230314

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Garner Todd W
- **CENTRAL INDEX KEY:** 0001726884

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39218
- **FILM NUMBER:** 23730684

**MAIL ADDRESS:**
- **STREET 1:** C/O CONMED CORPORATION
- **STREET 2:** 11311 CONCEPT BOULEVARD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773

**FORMER NAME:**
- **FORMER CONFORMED NAME:** Garner Todd W.
- **DATE OF NAME CHANGE:** 20180102
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CONMED Corp
- **CENTRAL INDEX KEY:** 0000816956
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **IRS NUMBER:** 160977505
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 11311 CONCEPT BOULEVARD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773
- **BUSINESS PHONE:** 727-214-2974

**MAIL ADDRESS:**
- **STREET 1:** 11311 CONCEPT BOULEVARD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CONMED CORP
- **DATE OF NAME CHANGE:** 19920703

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Garner Todd W<br><sub>(Last) (First) (Middle)</sub><br>C/O CONMED CORPORATION<br>11311 CONCEPT BOULEVARD<br><sub>(Street)</sub><br>LARGO, FL 33773<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-13 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Executive Vice President & CFO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CONMED Corp [ CNMD ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-13 |  | M<sup>(1)</sup> |  | 30000 | A | $50.61 | 31115 | D |  |
| Common Stock | 2023-03-13 |  | S |  | 1300 | D | 88.7819<sup>(2)</sup> | 29815 | D |  |
| Common Stock | 2023-03-13 |  | S |  | 6849 | D | 90.3044<sup>(3)</sup> | 22966 | D |  |
| Common Stock | 2023-03-13 |  | S |  | 17926 | D | 91.1009<sup>(4)</sup> | 5040 | D |  |
| Common Stock | 2023-03-13 |  | S |  | 3825 | D | 91.9452<sup>(5)</sup> | 1215 | D |  |
| Common Stock | 2023-03-13 |  | S |  | 100 | D | $92.63 | 1115 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Options To Purchase Common Stock | $50.61 | 2023-03-13 |  | M |  |  | 30000 | <sup>(6)</sup> | 2028-01-02 | Common Stock | 30000 | $0 | 5100 | D |  |

---

### Footnotes:

(1) These trades were made pursuant to a plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

(2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.15 to $88.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

(3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.61 to $90.595. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

(4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.615 to $91.61. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

(5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.625 to $92.45. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

(6) Each Stock Option represents a contingent right to receive one share of common stock, par value $0.001, per share of Conmed Corporation (the "Company") and was granted outside of the Company's existing equity plan as "employment inducement grants" under NASDAQ Listing Rule 5635(c)(4) and vest in equal amounts (20%) over a five year period on the January 2 anniversary date of the award, as further described in the Current Report filed with the SEC by the Company on January 2, 2018.

**Signature:** Daniel S. Jonas for Todd W. Garner by Power of Attorney  
**Date:** 2023-03-14

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**